HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (herpevac trial for women)

Southern Medical Journal

Volumn 107, Issue 2, 2014, Pages 79-84

  Schulte, Joann M ^{a,b,c,d,e,f,g}   Bellamy, Abbie R ^a,b,c,d,e,f   Hook, Edward W ^a,b,c,d,e,f   Bernstein, David I ^a,b,c,d,e,f   Levin, Myron J ^a,b,c,d,e,f   Leone, Peter A ^a,b,c,d,e,f   Sokol Anderson, Marcia L ^a,b,c,d,e,f   Ewell, Marian G ^a,b,c,d,e,f   Wolff, Peter A ^a,b,c,d,e,f   Heineman, Thomas C ^a,b,c,d,e,f   Belshe, Robert B ^a,b,c,d,e,f  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f GLAXOSMITHKLINE   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Herpes simplex; Seroprevalence

Indexed keywords

HERPES SIMPLEX VACCINE; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; ASYMPTOMATIC INFECTION; AWARENESS; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; NEGRO; NONHUMAN; SEROPREVALENCE; UNITED STATES; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; ANTIBODIES, VIRAL; BLOTTING, WESTERN; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MASS SCREENING; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84898430636     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0000000000000062     Document Type: Article

References (28)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296: 964-973.
2. Lafferty WE, Downey L, Celum C, et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181: 1454-1457.
3. Pena KC, Adelson ME,Mordechai E, et al. Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J Clin Microbiol 2010;48: 150-153.
4. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003;30: 797-800.
5. Ribes JA, Steele AD, Seabolt JP, et al. Six-year study of the incidence of herpes and genital in nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001;39: 3321-3325.
6. Lowhagen GB, Tunback P, Andersson K, et al. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing in specific serology. Sex Transm Infect 2000;76: 179-182.
7. Vyse AJ, Gay NJ, Slomka J, et al. The burden of infection with HSV-1 and HSV-2 in England andWales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76: 183-187.
8. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004;80: 185-191.
9. Forward KR, Lee SH. Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. Can J Infect Dis 2003; 14: 94-96.
10. Howard M, Sellors JW, Jang D, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003;41: 84-89.
11. Tran T, Druce JD, Catton MC, et al. Changing epidemiology of genital herpes simplex virus infection Melbourne, Australia, between 1980 and 2003. Sex Transm Infect 2004;80: 277-279.
12. Ryder N, Jin F, McNulty AM, et al. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect 2009;85: 416-419.
13. Centers for Disease Control and Prevention. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 yearsVUnited States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010;59: 456-459.
14. Xu F, Lee FK, Morrow RA, et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr 2007;151: 374-377.
15. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012;366: 34-43.
16. Ashley RL, Militoni J, Lee F, et al. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988;26: 662-667.
17. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2009. www.cdc.gov/StD/stats09/default.htm. Accessed December 20, 2013.
18. Census Bureau Regions and Divisions with State FIPS Codes. Department of Commerce, US Census Bureau. www.census.gov/popest/about/geo/state-geocodes- v2011.xls. Accessed December 20, 2013.
19. Kroop RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006;117: 1955-1962.
20. Brown ZA, Wald A, Morrow RA, et al. Effect of serological status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289: 203-209.
21. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1995;10: 432-442.
22. Celum C,Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV- 1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362: 427-439.
23. Schacker T, Zeh J,Hu H, et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002;186: 1718-1725.
24. Corey L,Wald A, Patel R, et al. Once-daily valcyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350: 11-20.
25. Fife KH, Williams JA, Thomas AL, et al. Herpes simplex virus type 2 infection in young adult women: risk factors for infection and frequency of viral shedding. Sex Transm Dis 2010;37: 248-252.
26. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333: 770-775.
27. Sanders SA, Reinisch JM. Would you say you ''had sex'' if I? JAMA 1999;281: 275-277.
28. Sanders SA, Hill BJ, Yarber WL, et al. Misclassification bias: diversity in conceptualizations about having ''had sex.'' Sex Health 2010;7: 31-34.